BHVN
Envestnet Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,174
| Closed | -$480K | – | 4146 |
|
|
2022
Q3 | $480K | Sell |
3,174
-30,030
| -90% | -$4.54M | ﹤0.01% | 3043 |
|
|
2022
Q2 | $4.84M | Buy |
33,204
+3,355
| +11% | +$489K | ﹤0.01% | 1542 |
|
|
2022
Q1 | $3.54M | Buy |
29,849
+3,305
| +12% | +$392K | ﹤0.01% | 1820 |
|
|
2021
Q4 | $3.66M | Buy |
26,544
+21,925
| +475% | +$3.02M | ﹤0.01% | 1773 |
|
|
2021
Q3 | $642K | Buy |
4,619
+856
| +23% | +$119K | ﹤0.01% | 2816 |
|
|
2021
Q2 | $365K | Buy |
3,763
+294
| +8% | +$28.5K | ﹤0.01% | 3170 |
|
|
2021
Q1 | $237K | Buy |
3,469
+776
| +29% | +$53K | ﹤0.01% | 3257 |
|
|
2020
Q4 | $231K | Buy |
+2,693
| New | +$231K | ﹤0.01% | 3061 |
|
|
2020
Q3 | – | Sell |
-3,535
| Closed | -$258K | – | 3253 |
|
|
2020
Q2 | $258K | Buy |
+3,535
| New | +$258K | ﹤0.01% | 2756 |
|
|
2019
Q2 | – | Sell |
-3,877
| Closed | -$200K | – | 3140 |
|
|
2019
Q1 | $200K | Buy |
+3,877
| New | +$200K | ﹤0.01% | 2836 |
|
|
2018
Q3 | – | Sell |
-1,226
| Closed | -$48K | – | 3206 |
|
|
2018
Q2 | $48K | Buy |
1,226
+140
| +13% | +$5.48K | ﹤0.01% | 2222 |
|
|
2018
Q1 | $28K | Buy |
1,086
+552
| +103% | +$14.2K | ﹤0.01% | 2300 |
|
|
2017
Q4 | $14K | Sell |
534
-559
| -51% | -$14.7K | ﹤0.01% | 2582 |
|
|
2017
Q3 | $41K | Buy |
1,093
+104
| +11% | +$3.9K | ﹤0.01% | 2336 |
|
|
2017
Q2 | $25K | Buy |
+989
| New | +$25K | ﹤0.01% | 2555 |
|